Xilio Therapeutics, Inc. (XLO)

Xilio Therapeutics Revenue

Xilio Therapeutics had revenue of $9.98M in the quarter ending September 30, 2026, a decrease of -47.63%. This brings the company's total for the last twelve months to $55.01M, up 72.97% year-over-year. In the year 2025, Xilio Therapeutics had annual revenue of $43.77M with 589.88% growth. That makes Xilio Therapeutics the 27,281st largest company in the world by revenue and 3,709th in the United States.

• Revenue (ttm): $55.01M
• Revenue Growth: +72.97%
• P/S Ratio: 1.01
• Revenue / Employee: $723,816
• Employees: 76
• Market Cap: 55.73M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	43.77M	37.42M	589.88%
Dec 31, 2024	6.34M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Nov 10, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error